EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 167 filers reported holding EVOLENT HEALTH INC in Q3 2017. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,363 | -6.6% | 144 | 0.0% | 0.00% | – |
Q1 2023 | $4,672 | -87.7% | 144 | -89.7% | 0.00% | – |
Q4 2021 | $38,000 | -11.6% | 1,400 | 0.0% | 0.00% | – |
Q3 2021 | $43,000 | +48.3% | 1,400 | 0.0% | 0.00% | – |
Q2 2021 | $29,000 | +3.6% | 1,400 | 0.0% | 0.00% | – |
Q1 2021 | $28,000 | -98.6% | 1,400 | -98.9% | 0.00% | -100.0% |
Q4 2020 | $2,008,000 | +30.6% | 125,300 | +1.1% | 0.02% | +7.1% |
Q3 2020 | $1,537,000 | +74.3% | 123,900 | 0.0% | 0.01% | +55.6% |
Q2 2020 | $882,000 | +22.0% | 123,900 | -7.1% | 0.01% | -10.0% |
Q1 2020 | $723,000 | -84.3% | 133,300 | -73.8% | 0.01% | -81.1% |
Q4 2019 | $4,598,000 | +91.4% | 508,200 | +52.1% | 0.05% | +76.7% |
Q3 2019 | $2,402,000 | -20.4% | 334,150 | -12.0% | 0.03% | -23.1% |
Q2 2019 | $3,019,000 | +140.0% | 379,840 | +279.8% | 0.04% | +129.4% |
Q1 2019 | $1,258,000 | -65.1% | 100,000 | -50.6% | 0.02% | -57.5% |
Q3 2017 | $3,604,000 | +469.4% | 202,500 | +710.0% | 0.04% | +400.0% |
Q2 2017 | $633,000 | +2537.5% | 25,000 | +2172.7% | 0.01% | – |
Q1 2017 | $24,000 | +50.0% | 1,100 | 0.0% | 0.00% | – |
Q4 2016 | $16,000 | – | 1,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Voce Capital Management LLC | 323,694 | $9,807,928 | 16.97% |
Engaged Capital LLC | 1,747,252 | $52,941,736 | 7.66% |
Greenhouse Funds LLLP | 1,399,260 | $42,397,578 | 3.31% |
Rock Point Advisors, LLC | 330,448 | $10,012,574 | 3.29% |
FORMULA GROWTH LTD | 299,510 | $9,075,153 | 2.89% |
Rock Springs Capital Management LP | 3,803,500 | $115,246,050 | 2.74% |
Granahan Investment Management | 2,914,350 | $88,304,805 | 2.72% |
SECTORAL ASSET MANAGEMENT INC | 488,142 | $14,790,703 | 2.47% |
Summit Creek Advisors LLC | 557,070 | $16,879,221 | 2.11% |
Orbimed Advisors | 2,895,632 | $87,737,650 | 1.59% |